Skip to main content
. 2000 Apr 4;97(9):4796–4801. doi: 10.1073/pnas.070560797

Figure 4.

Figure 4

CTL of prostate cancer patient against hTRT are MHC Class I restricted. CTL lines 380.540.1 and 380.865.1 of a patient (no. 380) were tested in a 51Cr-labeled release assay by using as targets T2 cells pulsed with p540 (A) or p865 (B). The following inhibitory antibodies were used: murine monoclonal antibody BB7.2 (IgG2b) against MHC Class I, murine monoclonal antibody Q5/13 (IgG2a) against HLA-DR, and the engineered antibody γ1RGD3 that blocks NK cell function.